Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma substitution in paediatric neurosurgery: Voluven vs Plasmavolume
2010-019421-33Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hetastarch in neurological diseases (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Safety of repetitive large-dose infusion of hydroxyethyl starch formulations. Started Mar 2012; status: completed.
02
Drugs
hetastarch
03
Conditions
neurological diseases
Beyond the preview
Go deeper on 2010-019421-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019421-33.